Literature DB >> 15148503

Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature.

John A Ozolek1, Sydney D Finkelstein, Marta E Couce.   

Abstract

Few reported cases of gliosarcomas or glioblastomas with epithelial-like areas exist. Most cases were originally diagnosed as metastatic carcinoma. Focal expression of glial fibrillary acidic protein has helped characterize these tumors as having a glial origin. We report a case of gliosarcoma with multifocal, extensive areas of well-differentiated carcinoma; demonstrating squamous and glandular differentiation. The expression of glial fibrillary acidic protein and epithelial phenotype were mutually exclusive. We performed extensive immunohistochemical analyses and comparative genotypic analysis using microdissection to secure representative glial and epithelial components. Loss of heterozygosity was analyzed with a panel of 12 polymorphic microsatellite markers designed to indicate allelic loss and situated in proximity to known tumor suppressor genes located on chromosomes 1p, 9p, 10q, 17p and 19q. We found comparable patterns of acquired allelic loss between the glial and carcinomatous components, strongly supporting the monoclonal origin of this neoplasm. This case represents an extreme form of phenotypic divergence in a malignant glioma, and constitutes a difficult diagnostic challenge. This heterogeneity reflects the potential for a range of phenotypic expression in malignant gliomas that needs to be recognized. We suggest microdissection genotyping as a molecular technique to better characterize these tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15148503     DOI: 10.1038/modpathol.3800109

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Gliosarcoma: A rare primary CNS tumor. Presentation of two cases.

Authors:  José Pardo; Mauricio Murcia; Felip García; Arnaldo Alvarado
Journal:  Rep Pract Oncol Radiother       Date:  2010-07-07

2.  Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.

Authors:  Fausto J Rodriguez; Bernd W Scheithauer; Caterina Giannini; Sandra C Bryant; Robert B Jenkins
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

3.  Clinical, radiological, histological and molecular characteristics of paediatric epithelioid glioblastoma.

Authors:  A Broniscer; R G Tatevossian; N D Sabin; P Klimo; J Dalton; R Lee; A Gajjar; D W Ellison
Journal:  Neuropathol Appl Neurobiol       Date:  2014-04       Impact factor: 8.090

4.  Multi-focal gliosarcoma: a case report and review of the literature.

Authors:  E E Pakos; A C Goussia; V P Zina; E J Pitouli; P G Tsekeris
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

5.  Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype.

Authors:  Laura J Lewis-Tuffin; Fausto Rodriguez; Caterina Giannini; Bernd Scheithauer; Brian M Necela; Jann N Sarkaria; Panos Z Anastasiadis
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Analysis of a synchronous gliosarcoma and meningioma with long survival: A case report and review of the literature.

Authors:  Paulo Linhares; Olga Martinho; Bruno Carvalho; Lígia Castro; José Manuel Lopes; Rui Vaz; Rui Manuel Reis
Journal:  Surg Neurol Int       Date:  2013-11-27

7.  Composite pleomorphic xanthoastrocytoma-epithelioid glioneuronal tumor with BRAF V600E mutation - report of three cases.

Authors:  Dara L Aisner; Kathy L Newell; Ania G Pollack; Bette K Kleinschmidt-Demasters; Gary K Steinberg; Lawrence T Smyth; Hannes Vogel
Journal:  Clin Neuropathol       Date:  2014 Mar-Apr       Impact factor: 1.368

8.  Giant parieto-occipital lobe pediatric gliosarcoma: Report of a rare entity and review of literature.

Authors:  Gautam Dutta; Robin Gupta; Manish Garg; Daljit Singh; Hukum Singh; Arvind K Srivastava; Anita Jagetia
Journal:  Surg Neurol Int       Date:  2018-05-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.